L-methylfolate: a vitamin for your monoamines.

  title={L-methylfolate: a vitamin for your monoamines.},
  author={Stephen M Stahl},
  journal={The Journal of clinical psychiatry},
  volume={69 9},
  • S. Stahl
  • Published 30 September 2008
  • Chemistry
  • The Journal of clinical psychiatry
Synthesis of the monoamine neurotransmitters serotonin, dopamine, and norepinephrine is regulated by L-methylfolate, a derivate of the vitamin folate. 

Figures from this paper

Folate, vitamin B₁₂, and S-adenosylmethionine.
Epigenetics and methylomics in psychiatry.
  • S. Stahl
  • Psychology, Biology
    The Journal of clinical psychiatry
  • 2009
Not all inherited traits, including psychiatric disorders, are due to changes in the DNA sequence of genes, in fact, many characteristics of cells are due instead to the selective activating and silencing of genes in a dynamic process known as epigenetics.
Folate in depression: efficacy, safety, differences in formulations, and clinical issues.
Several forms of folate appear to be safe and efficacious in some individuals with major depressive disorder, but more information is needed about dosage and populations most suited to folate therapy.
Folates and S-Adenosylmethionine for Major Depressive Disorder
Although further randomized controlled trials in this area appear warranted, SAMe and L-methylfolate may represent a useful addition to the AD armamentarium and appear to be efficacious and well tolerated in reducing depressive symptoms.
Enhancement of recovery from mental illness with l-methylfolate supplementation.
  • G. Martone
  • Psychology, Medicine
    Perspectives in psychiatric care
  • 2018
People suffering from depression, schizophrenia, and dementia often have measurably lower levels of serum folate compared to people not experiencing psychiatric disorders. Augmentation of SSRI and
Vitamin B Supplementation: What's the Right Choice for Your Patients?
  • L. Leahy
  • Medicine, Psychology
    Journal of psychosocial nursing and mental health services
  • 2017
Exploring the conversion of folate/folic acid into L-methylfolate and the various polymorphisms of the MTHFR gene and examining the B vitamins associated with the treatment of psychiatric symptoms will further allow nurses to comprehensively treat their patients with the appropriate B vitamins.
[Folates in the treatment of depression].
The evidence for L-methylfolate and folic acid as antidepressive agents in depression is reviewed and their clinical use is discussed.
Impact of Supplementation and Nutritional Interventions on Pathogenic Processes of Mood Disorders: A Review of the Evidence
This narrative review was conducted using searches of the PubMed/Medline and Google Scholar databases from inception to November 2019. Clinical trials and relevant articles were identified by
Folate, DNA damage and the aging brain
  • M. Fenech
  • Biology
    Mechanisms of Ageing and Development
  • 2010
Good, better, best: clinical scenarios for the use of L-methylfolate in patients with MDD
Recent advances in the pathophysiology of major depressive disorder as it pertains to folate and associated biomarkers are highlighted and the profiles of patients with depression who could benefit most from supplemental use of L-methylfolate are established.


The effect of tetrahydrofolate on tetrahydrobiopterin metabolism.
Patients with senile dementia could possibly be benefited by the administration of 5-methyltetrahydrofolate and vitamin B12, which appear to be required for the biosynthesis of tetRahydrobiopterin.
Novel Therapeutics for Depression: L-methylfolate as a Trimonoamine Modulator and Antidepressant-Augmenting Agent
The putative mechanism of action of MTHF as an augmenting agent to antidepressants is that it acts as a trimonoamine modulator (TMM), enhancing the synthesis of the three monoamines: dopamine (DA), norepinephrine (NE), and serotonin (5-HT), resulting in a boost to the efficacy of antidepressants.
Folate deficiency, biopterin and monoamine metabolism in depression
These observations provide further evidence of the links between folate, biopterin and monoamine metabolism in depression and for all depressed patients red-cell folate was significantly correlated with CSF 5HIAA and homovanillic acid (HVA).
Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders: a HuGE review.
An association between the MTHFR C677T variant and depression, schizophrenia, and bipolar disorder is demonstrated, raising the possibility of the use of folate in treatment and prevention.
Is low folate a risk factor for depression? A meta-analysis and exploration of heterogeneity
There is accumulating evidence that low folate status is associated with depression and definitive randomised-controlled trials to test the therapeutic benefit of folate are required to confirm or refute a causal relationship.
Folic acid: neurochemistry, metabolism and relationship to depression
The few studies available suggest folic acid has either antidepressant properties or can act as an augmenting agent for standard antidepressant treatment, although there is substantial evidence of the association between depressive disorder (particularly severe depression) and low folic Acid levels.
The relationship between brain folate and monoamine metabolism
  • Botez MI, Reynolds EH, eds. Folic Acid in Neurology, Psychiatry and Internal Medicine
  • 1979